Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioconjugate Chemistry|July 14, 2026
Receptor-Targeted Folic Acid Ligand-Drug Conjugate of Exatecan Leads to Complete Tumor Regression in the Preclinical Tumor ModelDhanashree Murugan, Loganathan Rangasamy
Non-Coding RNA Research|October 20, 2022
A perspective to weaponize microRNAs against lung cancerDhanashree Murugan, Loganathan Rangasamy
Molecular and Cellular Biochemistry|November 17, 2022
Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19Dhanashree Murugan, Loganathan Rangasamy
RSC Advances|August 1, 2026
Hitting the bullseye: PSMA-targeted small molecule drug conjugate for prostate cancer treatmentDhanashree Murugan, Loganathan Rangasamy
Antibiotics (Basel, Switzerland)|December 30, 2025
Correction: Venkatesan et al. A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery. Antibiotics 2022, 11, 1717Janarthanan Venkatesan, Dhanashree Murugan, Loganathan Rangasamy
Antibiotics (Basel, Switzerland)|December 23, 2022
A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug DiscoveryJanarthanan Venkatesan, Dhanashree Murugan, Loganathan Rangasamy
Cancers|November 11, 2022
Nanoparticle Enhancement of Natural Killer (NK) Cell-Based ImmunotherapyDhanashree Murugan, Vasanth Murugesan, Balaji Panchapakesan, et al.
Polymers|April 23, 2022
Can 3D-Printed Bioactive Glasses Be the Future of Bone Tissue Engineering?Amey Dukle, Dhanashree Murugan, Arputharaj Joseph Nathanael, et al.
RSC Advances|May 20, 2025
New spirooxindole pyrrolidine/pyrrolizidine analogs: design, synthesis, and evaluation as an anticancer agentNarayanasamy Nivetha, Janarthanan Venkatesan, Dhanashree Murugan, et al.
ACS Infectious Diseases|June 21, 2024
Siderophore-Conjugated Antifungals: A Strategy to Potentially Cure Fungal InfectionsKalaiarasu Lakshminarayanan, Dhanashree Murugan, Janarthanan Venkatesan, et al.
Pageof 2